These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 2969151)
1. Use of [3H]trimetoquinol as a radioligand in human platelets: interaction with putative endoperoxide/thromboxane A2 receptor sites. Ahn CH; Wallace LJ; Miller DD; Feller DR Thromb Res; 1988 May; 50(3):387-99. PubMed ID: 2969151 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade. Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894 [TBL] [Abstract][Full Text] [Related]
3. Pharmacologic antagonism of thromboxane A2 receptors by trimetoquinol analogs in vitro and in vivo. Shin Y; Romstedt KJ; Doyle K; Harrold MW; Gerhardt MA; Miller DD; Patil PN; Feller DR Chirality; 1991; 3(2):112-7. PubMed ID: 1830752 [TBL] [Abstract][Full Text] [Related]
4. Halogen-substituted trimetoquinol analogs as thromboxane A2 receptor antagonists in platelets and aorta. Romstedt KJ; Shin Y; Shams G; Doyle K; Tantishaiyakul V; Clark MT; Adejare A; Hamada A; Miller DD; Feller DR Biochem Pharmacol; 1993 Dec; 46(11):2051-9. PubMed ID: 8267653 [TBL] [Abstract][Full Text] [Related]
5. Interactions of nonprostanoid trimetoquinol analogs with thromboxane A2/prostaglandin H2 receptors in human platelets, rat vascular endothelial cells and rat vascular smooth muscle cells. Shin Y; Romstedt KJ; Miller DD; Feller DR J Pharmacol Exp Ther; 1993 Dec; 267(3):1017-23. PubMed ID: 7903383 [TBL] [Abstract][Full Text] [Related]
6. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta. Mukhopadhyay A; Navran SS; Amin HM; Abdel-Aziz SA; Chang J; Sober DJ; Miller DD; Feller DR J Pharmacol Exp Ther; 1985 Jan; 232(1):1-9. PubMed ID: 3855323 [TBL] [Abstract][Full Text] [Related]
7. Antagonism of prostaglandin-mediated responses in platelets and vascular smooth muscle by 13-azaprostanoic acid analogs. Evidence for selective blockade of thromboxane A2 responses. Huzoor-Akbar ; Mukhopadhyay A; Anderson KS; Navran SS; Romstedt K; Miller DD; Feller DR Biochem Pharmacol; 1985 Mar; 34(5):641-7. PubMed ID: 3156599 [TBL] [Abstract][Full Text] [Related]
8. Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes. Hung SC; Ghali NI; Venton DL; Le Breton GC Biochim Biophys Acta; 1983 Feb; 728(2):171-8. PubMed ID: 6219702 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological evaluation of the beta-adrenoceptor agonist and thromboxane receptor blocking properties of 1-benzyl substituted trimetoquinol analogues. Shams G; Romstedt KJ; Gerhardt MA; Harrold MW; Miller DD; Feller DR Eur J Pharmacol; 1990 Aug; 184(1):21-31. PubMed ID: 1976530 [TBL] [Abstract][Full Text] [Related]
10. Selective modulation of the human platelet thromboxane A2/prostaglandin H2 receptor by eicosapentaenoic and docosahexaenoic acids in intact platelets and solubilized platelet membranes. Parent CA; Lagarde M; Venton DL; Le Breton GC J Biol Chem; 1992 Apr; 267(10):6541-7. PubMed ID: 1532390 [TBL] [Abstract][Full Text] [Related]
11. 12-HETE inhibits the binding of PGH2/TXA2 receptor ligands in human platelets. Fonlupt P; Croset M; Lagarde M Thromb Res; 1991 Jul; 63(2):239-48. PubMed ID: 1837628 [TBL] [Abstract][Full Text] [Related]
12. A photoaffinity label for the thromboxane A2/prostaglandin H2 receptor in human blood platelets. Kattelman EJ; Arora SK; Lim CT; Venton DL; Le Breton GC FEBS Lett; 1987 Mar; 213(1):179-83. PubMed ID: 2951273 [TBL] [Abstract][Full Text] [Related]
13. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor. Sato T; Hashizume T; Nakao K; Akiba S; Fujii T Biochim Biophys Acta; 1989 Aug; 992(2):168-73. PubMed ID: 2503041 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and platelet antiaggregatory activity of trimetoquinol analogs as endoperoxide/thromboxane A2 antagonists. Harrold MW; Gerhardt MA; Romstedt K; Feller DR; Miller DD Drug Des Deliv; 1987 Feb; 1(3):193-207. PubMed ID: 3509333 [TBL] [Abstract][Full Text] [Related]
15. Binding characteristics of the new thromboxane A2/prostaglandin H2 receptor antagonist [3H]BAY U 3405 to washed human platelets and platelet membranes. Theis JG; Dellweg H; Perzborn E; Gross R Biochem Pharmacol; 1992 Aug; 44(3):495-503. PubMed ID: 1387312 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological evaluation of the beta-adrenoceptor agonist and thromboxane antagonist properties of N-substituted trimetoquinol analogues. Fedyna JS; Adejare A; Miller DD; Feller DR Eur J Pharmacol; 1987 Mar; 135(2):161-71. PubMed ID: 2884118 [TBL] [Abstract][Full Text] [Related]
18. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets. Turini ME; Holub BJ Biochim Biophys Acta; 1994 Jun; 1213(1):21-6. PubMed ID: 8011675 [TBL] [Abstract][Full Text] [Related]
19. Binding of a thromboxane A2/prostaglandin H2 agonist [3H]U46619 to washed human platelets. Liel N; Mais DE; Halushka PV Prostaglandins; 1987 Jun; 33(6):789-97. PubMed ID: 2959986 [TBL] [Abstract][Full Text] [Related]
20. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. Yin K; Halushka PV; Yan YT; Wong PY J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]